Literature DB >> 29313448

Association of Time between Surgery and Adjuvant Therapy with Survival in Oral Cavity Cancer.

Michelle M Chen1, Jeremy P Harris2, Ryan K Orosco1, Davud Sirjani1, Wendy Hara2, Vasu Divi1.   

Abstract

Objective The National Cancer Center Network recommends starting radiation therapy within 6 weeks after surgery for oral cavity squamous cell carcinoma (OCSCC), but there is limited evidence of the importance of the total time from surgery to completion of radiation therapy (package time). We set out to determine if there was an association between package time and survival in OCSCC and to evaluate the impact of treatment location on outcomes. Study Design Retrospective cohort study. Setting Tertiary academic medical center. Subjects and Methods We reviewed the records of patients with OCSCC who completed postoperative radiation therapy at an academic medical center from 2008 to 2016. The primary endpoints were overall survival and recurrence-free survival. Statistical analysis included χ2 tests and Cox proportional hazards regressions. Results We identified 132 patients with an average package time of 12.6 weeks. On multivariate analysis, package time >11 weeks was independently associated with decreased overall survival (hazard ratio, 6.68; 95% CI, 1.42-31.44) and recurrence-free survival (hazard ratio, 2.94; 95% CI, 1.20-7.18). Patients who received radiation therapy at outside facilities were more likely to have treatment delays (90.2% vs 62.9%, P = .001). Conclusions Prolonged package times are associated with decreased overall and recurrence-free survival among patients with OCSCC. Patients who received radiation therapy at outside facilities are more likely to have prolonged package times.

Entities:  

Keywords:  oral cavity; package time; quality of care; radiation therapy; treatment delay; treatment time

Mesh:

Year:  2018        PMID: 29313448     DOI: 10.1177/0194599817751679

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  10 in total

1.  Prognostic factors associated with achieving total oral diet after glossectomy with microvascular free tissue transfer reconstruction.

Authors:  Diane W Chen; Tao Wang; Jonathan Shey-Sen Ni; Vlad C Sandulache; Evan M Graboyes; Mitchell Worley; Joshua D Hornig; Judith M Skoner; Terry A Day; Andrew T Huang
Journal:  Oral Oncol       Date:  2019-03-28       Impact factor: 5.337

2.  Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer.

Authors:  Evan M Graboyes; Chanita Hughes Halbert; Hong Li; Graham W Warren; Anthony J Alberg; Elizabeth A Calhoun; Brian Nussenbaum; Courtney H Marsh; Jessica McCay; Terry A Day; John M Kaczmar; Anand K Sharma; David M Neskey; Katherine R Sterba
Journal:  JCO Oncol Pract       Date:  2020-08-27

3.  Association of Care Processes With Timely, Equitable Postoperative Radiotherapy in Patients With Surgically Treated Head and Neck Squamous Cell Carcinoma.

Authors:  Tyler A Janz; Joanne Kim; Elizabeth G Hill; Katherine Sterba; Graham Warren; Anand K Sharma; Terry A Day; Chanita Hughes-Halbert; Evan M Graboyes
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-12-01       Impact factor: 6.223

4.  Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma.

Authors:  Dylan A Levy; Hong Li; Katherine R Sterba; Chanita Hughes-Halbert; Graham W Warren; Brian Nussenbaum; Anthony J Alberg; Terry A Day; Evan M Graboyes
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-05-01       Impact factor: 6.223

5.  Early institutional head and neck oncologic and microvascular surgery practice patterns across the United States during the SARS-CoV-2 (COVID19) pandemic.

Authors:  Rusha J Patel; Alexandra Kejner; Caitlin McMullen
Journal:  Head Neck       Date:  2020-04-28       Impact factor: 3.147

Review 6.  An equity-based narrative review of barriers to timely postoperative radiation therapy for patients with head and neck squamous cell carcinoma.

Authors:  Elizabeth A Noyes; Ciersten A Burks; Andrew R Larson; Daniel G Deschler
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-11-09

7.  Duration of radiation therapy is associated with worse survival in head and neck cancer.

Authors:  Angela L Mazul; Katelyn O Stepan; Thomas F Barrett; Wade L Thorstad; Sean Massa; Douglas R Adkins; Mackenzie D Daly; Jason T Rich; Randal C Paniello; Patrik Pipkorn; Jose P Zevallos; Ryan S Jackson; Stephen Y Kang; Sidharth V Puram
Journal:  Oral Oncol       Date:  2020-05-30       Impact factor: 5.337

8.  Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer.

Authors:  Evan M Graboyes; Katherine R Sterba; Hong Li; Graham W Warren; Anthony J Alberg; Elizabeth A Calhoun; Brian Nussenbaum; Jessica McCay; Courtney H Marsh; Nosayaba Osazuwa-Peters; David M Neskey; John M Kaczmar; Anand K Sharma; Jennifer Harper; Terry A Day; Chanita Hughes-Halbert
Journal:  JCO Oncol Pract       Date:  2021-03-10

Review 9.  Framework for prioritizing head and neck surgery during the COVID-19 pandemic.

Authors:  Michael C Topf; Jared A Shenson; F Christopher Holsinger; Samuel H Wald; Lisa J Cianfichi; Eben L Rosenthal; John B Sunwoo
Journal:  Head Neck       Date:  2020-05-06       Impact factor: 3.147

10.  Association between hospital interval and survival in patients with oral cancer: A waiting time paradox.

Authors:  José Luis Lopez-Cedrún; Ana Otero-Rico; Inés Vázquez-Mahía; Juan Seoane; Lucía García-Caballero; Juan Manuel Seoane-Romero; Pablo Varela-Centelles
Journal:  PLoS One       Date:  2019-10-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.